- Home
- VIVS vs EKSO Comparison
VIVS vs EKSO Comparison
Compare VIVS & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIVS
- EKSO
- Stock Information
- Founded
- VIVS 2007
- EKSO 2005
- Country
- VIVS United States
- EKSO United States
- Employees
- VIVS N/A
- EKSO N/A
- Industry
- VIVS Biotechnology: Biological Products (No Diagnostic Substances)
- EKSO Medical/Dental Instruments
- Sector
- VIVS Health Care
- EKSO Health Care
- Exchange
- VIVS Nasdaq
- EKSO Nasdaq
- Market Cap
- VIVS 8.1M
- EKSO 7.7M
- IPO Year
- VIVS N/A
- EKSO N/A
- Fundamental
- Price
- VIVS $2.28
- EKSO $4.90
- Analyst Decision
- VIVS
- EKSO Strong Buy
- Analyst Count
- VIVS 0
- EKSO 2
- Target Price
- VIVS N/A
- EKSO $34.75
- AVG Volume (30 Days)
- VIVS 1.4M
- EKSO 46.8K
- Earning Date
- VIVS 11-12-2025
- EKSO 10-28-2025
- Dividend Yield
- VIVS N/A
- EKSO N/A
- EPS Growth
- VIVS N/A
- EKSO N/A
- EPS
- VIVS N/A
- EKSO N/A
- Revenue
- VIVS $142,000.00
- EKSO $14,749,000.00
- Revenue This Year
- VIVS $42.38
- EKSO N/A
- Revenue Next Year
- VIVS $15.42
- EKSO $49.96
- P/E Ratio
- VIVS N/A
- EKSO N/A
- Revenue Growth
- VIVS 94.52
- EKSO N/A
- 52 Week Low
- VIVS $1.41
- EKSO $2.73
- 52 Week High
- VIVS $21.96
- EKSO $14.97
- Technical
- Relative Strength Index (RSI)
- VIVS 43.02
- EKSO 48.52
- Support Level
- VIVS $2.05
- EKSO $5.00
- Resistance Level
- VIVS $3.20
- EKSO $5.27
- Average True Range (ATR)
- VIVS 0.31
- EKSO 0.41
- MACD
- VIVS -0.02
- EKSO -0.02
- Stochastic Oscillator
- VIVS 20.00
- EKSO 40.30
About VIVS VivoSim Labs Inc. Common Stock
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.